Reported rates before and during the Dobbs year
Abortions per 1,000 women ages 15–44 · Bars start at zero
View the data
| Measure | Value |
|---|---|
| 2021 | 11.6 |
| 2022 | 11.2 |
Issue guide · Reviewed
Reproductive policy includes abortion, contraception, fertility care, and support around pregnancy. States set many access rules, while federal law affects medication, funding, insurance, and cross-state disputes.
Abortions per 1,000 women ages 15–44 · Bars start at zero
| Measure | Value |
|---|---|
| 2021 | 11.6 |
| 2022 | 11.2 |
Travel, appointment availability, cost, and state restrictions can affect access even when a service is lawful somewhere. A national legal label does not describe every patient’s situation.
Supreme Court · Dobbs docketFDA regulation, prescribing rules, insurance coverage, and public funding each affect care. Approval of a drug does not decide every question about where it may be used.
FDA · mifepristone informationCDC’s voluntary reporting omits some jurisdictions and appears after the reference year. The 2022 figures should not be presented as a complete measure of care after subsequent legal changes.
CDC · Abortion Surveillance, United States, 2022Establish a federal access floor, enact federal restrictions, or leave more decisions to states. The debate includes constitutional authority and the scope of exceptions.
Expand insurance and public support or restrict funding based on objections to particular services. Distinguish contraception, fertility treatment, and abortion.
Set rules for remote prescribing, mailing, and cross-state enforcement. Patient privacy and conflicting state laws complicate implementation.
Selected laws, proposals, and implementation—not a complete legislative inventory.
Agency rules follow a separate process. A proposed rule is not a final rule, and a temporary court order is not a final merits decision.
Would establish federal protections for abortion access and restrict specified governmental limitations. It is a proposal, not an enacted nationwide access guarantee.
Women’s Health Protection Act · H.R. 12Supports family-planning services through grants. Program funding and participation rules are separate from FDA drug approval and state abortion law.
HHS · Title X family planning programFDA’s product information and program requirements are the primary federal source for medication regulation. State access restrictions and litigation require separate analysis.
FDA · mifepristone informationDecided · Jun 13, 2024
The Court held that the plaintiffs lacked standing to challenge FDA’s actions concerning mifepristone in that case.
Why it matters. The decision did not decide the merits of FDA’s safety judgment or resolve every later challenge to medication abortion.
Supreme Court · FDA v. Alliance docketDecided · Jun 24, 2022
The Court overruled Roe and Casey, holding that the federal Constitution does not confer a right to abortion.
Why it matters. States’ constitutional protections, federal statutes, and other legal disputes remain distinct questions.
Supreme Court · Dobbs docketAgency roles and organizational positions are different kinds of information.
Distinguish legislation introduced in Congress from protections or restrictions already in force.
Women’s Health Protection Act · H.R. 12Read the latest agency requirements and court orders; a standing decision is not a general merits endorsement.
FDA · mifepristone informationCompare data sources’ coverage, reference periods, and treatment of telehealth before combining totals.
CDC · Abortion Surveillance, United States, 2022How to tell if it’s working. Track maternal health, access to contraception and fertility care, pregnancy support, and the practical effects of access rules. Keep descriptive evidence separate from the moral judgments underlying policy choices.
Selected past records, not statements of a 2028 platform. State and federal actions have different scopes.
Sep 17, 2024 · Voted to advance debate on the Right to IVF Act.
Sep 17, 2024 · Voted against advancing debate on the Right to IVF Act.